(Q40358058)

English

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial

scientific article published on 27 January 2017

In more languages
default for all languages
No label defined

No description defined

Statements

Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial (English)
Jeremy M Shefner
Claude Desnuelle
Karen E Morrison
Rajat Mohindra
Jonathan Bullman
Arseniy Lavrov
NOG112264 Study Group

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit